ATP1B2 and laryngeal carcinoma: For laryngeal cancer, rs55831773, a cross ancestral splice variant, mapping to ATP1B2 was associated with increased risk (OR (95% CI) = 1.21 (1.13, 1.29), pmeta = 5.1 × 10−9).